ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Claryx emerged from stealth with $3.5 million in pre-seed funding. The company uses genomic surveillance to uncover hospital transmission chains, founded by two brothers after their grandmother contracted a hospital infection.
Tap to vote and see what everyone thinks.
Summary by ByteBrief